Logo

Orion Genomics Extends Subcontract for Tobacco Genome Initiative

Sep 08, 2004

This story has been updated from a previous version to include a comment from Orion Genomics.

 

NEW YORK, Sept. 8 (GenomeWeb News) - Orion Genomics has extended a subcontract with North CarolinaStateUniversityto sequence parts of the tobacco genome, doubling its payment as a result.

 

Under the extended agreement, the Tobacco Genome Initiative, led by NCSU investigators, will use Orion's GeneThresher technology to develop an overall map of the tobacco genome. In an initial phase, the initiative had evaluated several gene discovery methodologies, including Orion's.

 

Nathan Lakey, CEO of Orion Genomics, declined to reveal how much money the company will receive under the contract. The Tobacco Genome Initiative is funded with $17.6 million in total from Philip Morris USA.

Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.